Despite CB1R antagonists being effective in reducing drug reward and relapse in experimental animals (for comprehensive reviews, see [5, 43]), CB1R antagonists have significant adverse side effects including nausea, emesis, depression, and suicidal tendencies in humans [15, 44–48]. The gene discussed is CNR1; the disease is depressive disorder.